Wells Fargo’s Lineage Cell Therapeutics LCTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$25.3K Sell
27,827
-85,619
-75% -$77.7K ﹤0.01% 5294
2025
Q1
$51.2K Buy
113,446
+18,552
+20% +$8.38K ﹤0.01% 4938
2024
Q4
$47.7K Buy
94,894
+23,527
+33% +$11.8K ﹤0.01% 5012
2024
Q3
$64.6K Buy
71,367
+3,926
+6% +$3.55K ﹤0.01% 4853
2024
Q2
$67.3K Buy
67,441
+7,065
+12% +$7.05K ﹤0.01% 4800
2024
Q1
$89.4K Sell
60,376
-579
-0.9% -$857 ﹤0.01% 4583
2023
Q4
$66.4K Buy
60,955
+8,783
+17% +$9.57K ﹤0.01% 4736
2023
Q3
$61.6K Sell
52,172
-27,687
-35% -$32.7K ﹤0.01% 4731
2023
Q2
$113K Buy
79,859
+52,963
+197% +$74.7K ﹤0.01% 4699
2023
Q1
$40.3K Sell
26,896
-54
-0.2% -$81 ﹤0.01% 4984
2022
Q4
$31.5K Buy
26,950
+21,443
+389% +$25.1K ﹤0.01% 4758
2022
Q3
$6K Sell
5,507
-2,998
-35% -$3.27K ﹤0.01% 5527
2022
Q2
$13K Sell
8,505
-194,505
-96% -$297K ﹤0.01% 5352
2022
Q1
$312K Sell
203,010
-321,831
-61% -$495K ﹤0.01% 4435
2021
Q4
$1.29M Sell
524,841
-179,603
-25% -$440K ﹤0.01% 3651
2021
Q3
$1.78M Buy
704,444
+693,901
+6,582% +$1.75M ﹤0.01% 3579
2021
Q2
$30K Buy
10,543
+910
+9% +$2.59K ﹤0.01% 5432
2021
Q1
$22K Sell
9,633
-121,689
-93% -$278K ﹤0.01% 5757
2020
Q4
$231K Buy
131,322
+2,086
+2% +$3.67K ﹤0.01% 4882
2020
Q3
$121K Sell
129,236
-25,865
-17% -$24.2K ﹤0.01% 4994
2020
Q2
$135K Sell
155,101
-145,270
-48% -$126K ﹤0.01% 4896
2020
Q1
$249K Buy
300,371
+118,418
+65% +$98.2K ﹤0.01% 4387
2019
Q4
$162K Buy
181,953
+131,147
+258% +$117K ﹤0.01% 4901
2019
Q3
$50K Buy
50,806
+3,589
+8% +$3.53K ﹤0.01% 5271
2019
Q2
$52K Sell
47,217
-7,791
-14% -$8.58K ﹤0.01% 5251
2019
Q1
$73K Sell
55,008
-4,780
-8% -$6.34K ﹤0.01% 5136
2018
Q4
$55K Sell
59,788
-3,199
-5% -$2.94K ﹤0.01% 5206
2018
Q3
$130K Buy
62,987
+3,878
+7% +$8K ﹤0.01% 5015
2018
Q2
$106K Sell
59,109
-102,404
-63% -$184K ﹤0.01% 5126
2018
Q1
$380K Buy
161,513
+2,921
+2% +$6.87K ﹤0.01% 4470
2017
Q4
$298K Buy
158,592
+35,950
+29% +$67.6K ﹤0.01% 4609
2017
Q3
$304K Buy
122,642
+34,437
+39% +$85.4K ﹤0.01% 4527
2017
Q2
$243K Buy
88,205
+1,894
+2% +$5.22K ﹤0.01% 4516
2017
Q1
$260K Sell
86,311
-1,265
-1% -$3.81K ﹤0.01% 4497
2016
Q4
$277K Buy
87,576
+27,372
+45% +$86.6K ﹤0.01% 4428
2016
Q3
$206K Buy
60,204
+33,947
+129% +$116K ﹤0.01% 4306
2016
Q2
$61K Sell
26,257
-10,325
-28% -$24K ﹤0.01% 4914
2016
Q1
$93K Sell
36,582
-8,368
-19% -$21.3K ﹤0.01% 4709
2015
Q4
$149K Sell
44,950
-855
-2% -$2.83K ﹤0.01% 4482
2015
Q3
$112K Buy
45,805
+12,997
+40% +$31.8K ﹤0.01% 4629
2015
Q2
$96K Buy
32,808
+25,224
+333% +$73.8K ﹤0.01% 4911
2015
Q1
$31K Buy
7,584
+2,363
+45% +$9.66K ﹤0.01% 5014
2014
Q4
$16K Sell
5,221
-3,567
-41% -$10.9K ﹤0.01% 5236
2014
Q3
$22K Sell
8,788
-2,190
-20% -$5.48K ﹤0.01% 5097
2014
Q2
$27K Buy
10,978
+6,425
+141% +$15.8K ﹤0.01% 5090
2014
Q1
$12K Sell
4,553
-806
-15% -$2.12K ﹤0.01% 5202
2013
Q4
$15K Buy
5,359
+403
+8% +$1.13K ﹤0.01% 4973
2013
Q3
$15K Hold
4,956
﹤0.01% 4937
2013
Q2
$16K Buy
+4,956
New +$16K ﹤0.01% 4837